AAAAAA
Results:
1-12
|
Results: 12
Authors:
Reali, E
Greiner, JW
Corti, A
Gould, HJ
Bottazzoli, F
Paganelli, G
Schlom, J
Siccardi, AG
Citation: E. Reali et al., IgEs targeted on tumor cells: Therapeutic activity and potential in the design of tumor vaccines, CANCER RES, 61(14), 2001, pp. 5517-5522
Authors:
Lopalco, L
Pastori, C
Cosma, A
Burastero, SE
Capiluppi, B
Boeri, E
Beretta, A
Lazzarin, A
Siccardi, AG
Citation: L. Lopalco et al., Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity, AIDS RES H, 16(2), 2000, pp. 109-115
Authors:
Pastori, C
Barassi, C
Piconi, S
Longhi, R
Villa, ML
Siccardi, AG
Clerici, M
Lopalco, L
Citation: C. Pastori et al., HIV neutralizing IgA in exposed seronegative subjects recognise an epitopewithin the gp41 coiled-coil pocket, J BIOL REG, 14(1), 2000, pp. 15-21
Authors:
Barassi, C
De Santis, C
Pastori, C
Marraccini, P
Ciuffreda, D
Capiluppi, B
Bressi, C
Siccardi, AG
Lazzarin, A
Tambussi, G
Lopalco, L
Citation: C. Barassi et al., Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection, J BIOL REG, 14(1), 2000, pp. 68-74
Authors:
Lopalco, L
Barassi, C
Pastori, C
Longhi, R
Burastero, SE
Tambussi, G
Mazzotta, F
Lazzarin, A
Clerici, M
Siccardi, AG
Citation: L. Lopalco et al., CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro, J IMMUNOL, 164(6), 2000, pp. 3426-3433
Authors:
Guttinger, M
Guidi, F
Chinol, M
Reali, E
Veglia, F
Viale, G
Paganelli, G
Corti, A
Siccardi, AG
Citation: M. Guttinger et al., Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging, CANCER RES, 60(15), 2000, pp. 4211-4215
Authors:
Lopalco, L
Magnani, Z
Confetti, C
Brianza, M
Saracco, A
Ferraris, G
Lillo, F
Vegni, C
Lazzarin, A
Siccardi, AG
Burastero, SE
Citation: L. Lopalco et al., Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: A follow-up study, AIDS RES H, 15(12), 1999, pp. 1079-1085
Authors:
Pesenti, E
Pastore, C
Lillo, F
Siccardi, AG
Vercelli, D
Lopalco, L
Citation: E. Pesenti et al., Role of CD4 and CCR5 levels in the susceptibility of primary macrophages to infection by CCR5-dependent HIV type 1 isolates, AIDS RES H, 15(11), 1999, pp. 983-987
Authors:
Paganelli, G
Grana, C
Chinol, M
Cremonesi, M
De Cicco, C
De Braud, F
Robertson, C
Zurrida, S
Casadio, C
Zoboli, S
Siccardi, AG
Veronesi, U
Citation: G. Paganelli et al., Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin, EUR J NUCL, 26(4), 1999, pp. 348-357
Authors:
Cosma, A
Blanc, D
Braun, J
Quillent, C
Barassi, C
Moog, C
Klasen, S
Spire, B
Scarlatti, G
Pesenti, E
Siccardi, AG
Beretta, A
Citation: A. Cosma et al., Enhanced HIV infectivity and changes in GP120 conformation associated withviral incorporation of human leucocyte antigen class I molecules, AIDS, 13(15), 1999, pp. 2033-2042
Authors:
Mazzoli, S
Lopalco, L
Salvi, A
Trabattoni, D
Lo Caputo, S
Semplici, F
Biasin, M
Ble, C
Cosma, A
Pastori, C
Meacci, F
Mazzotta, F
Villa, ML
Siccardi, AG
Clerici, M
Citation: S. Mazzoli et al., Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons, J INFEC DIS, 180(3), 1999, pp. 871-875
Authors:
Gasparri, A
Moro, M
Curnis, F
Sacchi, A
Pagano, S
Veglia, F
Casorati, G
Siccardi, AG
Dellabona, P
Corti, A
Citation: A. Gasparri et al., Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models, CANCER RES, 59(12), 1999, pp. 2917-2923
Risultati:
1-12
|